Bijan Eghtesad

Summary

Affiliation: Cleveland Clinic Foundation
Country: USA

Publications

  1. ncbi request reprint Technical considerations in liver transplantation: what a hepatologist needs to know (and every surgeon should practice)
    Bijan Eghtesad
    Department of General Surgery, Cleveland Clinic Foundation, Cleveland, OH 44195, USA
    Liver Transpl 11:861-71. 2005
  2. ncbi request reprint Liver transplantation for malignancies
    Bijan Eghtesad
    Hepato Pancreato Biliary Liver Transplant Surgery, Cleveland Clinic, Desk A 100, 9500 Euclid Avenue, Cleveland, OH, 44195, USA
    J Gastrointest Cancer 45:353-62. 2014
  3. doi request reprint Hepatic blood flow plays an important role in ischemia-reperfusion injury
    Dympna M Kelly
    Department of General Surgery, Cleveland Clinic, Cleveland, OH 44195, USA
    Liver Transpl 17:1448-56. 2011
  4. doi request reprint Splenic artery embolization for the treatment of refractory ascites after liver transplantation
    Cristiano Quintini
    Department of Hepato pancreato biliary and Transplant Surgery, Digestive Disease Institute, Cleveland Clinic, Cleveland, OH 44106, USA
    Liver Transpl 17:668-73. 2011
  5. doi request reprint Measurement of CD4+ T-cell function in predicting allograft rejection and recurrent hepatitis C after liver transplantation
    Koji Hashimoto
    Departments of Hepato Pancreato Biliary and Transplant Surgery, Digestive Disease Institute, Cleveland Clinic, Cleveland, OH 44195, USA
    Clin Transplant 24:701-8. 2010
  6. doi request reprint Side-to-side cavocavostomy with an endovascular stapler: Rescue technique for severe hepatic vein and/or inferior vena cava outflow obstruction after liver transplantation using the piggyback technique
    Cristiano Quintini
    Department of General Surgery, Cleveland Clinic, Cleveland, OH 44195, USA
    Liver Transpl 15:49-53. 2009
  7. ncbi request reprint Radiologic-histological correlation of hepatocellular carcinoma treated via pre-liver transplant locoregional therapies
    Galal El-Gazzaz
    Hepatobiliary and Liver Transplant Surgery, Cleveland Clinic Foundation, Cleveland, OH 44120, USA
    Hepatobiliary Pancreat Dis Int 12:34-41. 2013
  8. ncbi request reprint Cruveilhier-Baumgarten disease in a patient with Turner syndrome: case report of a rare indication for liver transplantation
    Federico Aucejo
    Department of General Surgery, Cleveland Clinic, Cleveland, OH 44195, USA
    Liver Transpl 14:299-302. 2008
  9. doi request reprint Is impaired hepatic arterial buffer response a risk factor for biliary anastomotic stricture in liver transplant recipients?
    Koji Hashimoto
    Department of Hepato pancreato biliary and Transplant Surgery, Digestive Disease Institute, Cleveland Clinic, Cleveland, OH 44195, USA
    Surgery 148:582-8. 2010
  10. pmc Duct-to-duct biliary reconstruction in patients with primary sclerosing cholangitis undergoing liver transplantation
    Jamak Modaresi Esfeh
    Department of Internal Medicine, Hepato Pancreato Biliary Liver Transplant Surgery, Cleveland Clinic, Cleveland, OH 44195, USA
    HPB (Oxford) 13:651-5. 2011

Collaborators

Detail Information

Publications60

  1. ncbi request reprint Technical considerations in liver transplantation: what a hepatologist needs to know (and every surgeon should practice)
    Bijan Eghtesad
    Department of General Surgery, Cleveland Clinic Foundation, Cleveland, OH 44195, USA
    Liver Transpl 11:861-71. 2005
  2. ncbi request reprint Liver transplantation for malignancies
    Bijan Eghtesad
    Hepato Pancreato Biliary Liver Transplant Surgery, Cleveland Clinic, Desk A 100, 9500 Euclid Avenue, Cleveland, OH, 44195, USA
    J Gastrointest Cancer 45:353-62. 2014
    ..However, due to the high rate of tumor recurrence in a very short time after LT, especially in the era of organ shortage, this indication has not been favored by the transplant community. ..
  3. doi request reprint Hepatic blood flow plays an important role in ischemia-reperfusion injury
    Dympna M Kelly
    Department of General Surgery, Cleveland Clinic, Cleveland, OH 44195, USA
    Liver Transpl 17:1448-56. 2011
    ..In conclusion, this report demonstrates for the first time that reduced hepatic blood flow is a significant finding in patients with severe hepatic IR injury...
  4. doi request reprint Splenic artery embolization for the treatment of refractory ascites after liver transplantation
    Cristiano Quintini
    Department of Hepato pancreato biliary and Transplant Surgery, Digestive Disease Institute, Cleveland Clinic, Cleveland, OH 44106, USA
    Liver Transpl 17:668-73. 2011
    ..Clinically, this translated into a dramatic weight loss, a reduction of diuretic use, and a resolution of ascites. SAE appears to be a safe and effective treatment for RA...
  5. doi request reprint Measurement of CD4+ T-cell function in predicting allograft rejection and recurrent hepatitis C after liver transplantation
    Koji Hashimoto
    Departments of Hepato Pancreato Biliary and Transplant Surgery, Digestive Disease Institute, Cleveland Clinic, Cleveland, OH 44195, USA
    Clin Transplant 24:701-8. 2010
    ..In conclusion, the ImmuKnow assay can be a sensitive and specific additional test for distinguishing recurrent HCV from ACR and may be useful for predicting which recipients may be most vulnerable to recurrent HCV...
  6. doi request reprint Side-to-side cavocavostomy with an endovascular stapler: Rescue technique for severe hepatic vein and/or inferior vena cava outflow obstruction after liver transplantation using the piggyback technique
    Cristiano Quintini
    Department of General Surgery, Cleveland Clinic, Cleveland, OH 44195, USA
    Liver Transpl 15:49-53. 2009
    ..Both patients were treated successfully with side-to-side cavo-cavostomy using an endovascular (endo-GIA) stapler. This novel technique is fast and effective in resolving the outflow obstruction...
  7. ncbi request reprint Radiologic-histological correlation of hepatocellular carcinoma treated via pre-liver transplant locoregional therapies
    Galal El-Gazzaz
    Hepatobiliary and Liver Transplant Surgery, Cleveland Clinic Foundation, Cleveland, OH 44120, USA
    Hepatobiliary Pancreat Dis Int 12:34-41. 2013
    ..The aim of this study was to evaluate different levels of radiologic response after pre-liver transplant (LT) LRT and its correlation with percentage of tumor necrosis on explanted histopathology...
  8. ncbi request reprint Cruveilhier-Baumgarten disease in a patient with Turner syndrome: case report of a rare indication for liver transplantation
    Federico Aucejo
    Department of General Surgery, Cleveland Clinic, Cleveland, OH 44195, USA
    Liver Transpl 14:299-302. 2008
    ..Liver transplantation to treat this condition overcomes portal hypertension and reconstitutes the diminished hepatic function due to severe atrophy of the portal venous inflow...
  9. doi request reprint Is impaired hepatic arterial buffer response a risk factor for biliary anastomotic stricture in liver transplant recipients?
    Koji Hashimoto
    Department of Hepato pancreato biliary and Transplant Surgery, Digestive Disease Institute, Cleveland Clinic, Cleveland, OH 44195, USA
    Surgery 148:582-8. 2010
    ..Portal hyperperfusion impairs HAF due to the HABR in liver transplantation (LT). The aim of this study is to examine the effect of the HABR on biliary anastomotic stricture (BAS)...
  10. pmc Duct-to-duct biliary reconstruction in patients with primary sclerosing cholangitis undergoing liver transplantation
    Jamak Modaresi Esfeh
    Department of Internal Medicine, Hepato Pancreato Biliary Liver Transplant Surgery, Cleveland Clinic, Cleveland, OH 44195, USA
    HPB (Oxford) 13:651-5. 2011
    ..Over recent years, the traditional method of Roux-en-Y hepaticojejunostomy (RY) has been challenged by duct-to-duct (DD) biliary reconstruction...
  11. ncbi request reprint "Splenic artery steal syndrome" is a misnomer: the cause is portal hyperperfusion, not arterial siphon
    Cristiano Quintini
    Department of General Surgery, Liver Transplant Center, Cleveland, OH 44195, USA
    Liver Transpl 14:374-9. 2008
    ..6, 0.72, 0.86, and 0.68, in patients 1-4, respectively. SAE reduces excessive portal vein flow and thereby ameliorates an overactive HABR that can cause graft dysfunction and ultimately HA thrombosis...
  12. pmc Loco-regional therapy in patients with Milan Criteria-compliant hepatocellular carcinoma and short waitlist time to transplant: an outcome analysis
    Achuthan Sourianarayanane
    Departments of Gastroenterology and Hepatology Transplant Surgery, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA
    HPB (Oxford) 14:325-32. 2012
    ..However, its benefit in patients with a brief waiting time to transplant remains unclear. This study evaluated outcomes in patients with short waitlist times to LT for MC-compliant HCC...
  13. ncbi request reprint Three-dimensional print of a liver for preoperative planning in living donor liver transplantation
    Nizar N Zein
    Department of Gastroenterology and Hepatology, Digestive Disease Institute, Cleveland, OH
    Liver Transpl 19:1304-10. 2013
    ..Using standardized preoperative, intraoperative, and postoperative assessments, we demonstrated identical anatomical and geometrical landmarks in the 3D-printed models and native livers...
  14. ncbi request reprint Association between donor-recipient serum sodium differences and orthotopic liver transplant graft function
    Jacek B Cywinski
    Department of General Anesthesiology, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland Clinic, Cleveland, OH 44195, USA
    Liver Transpl 14:59-65. 2008
    ..02). The use of HTK preservation solution was associated with higher mean postoperative aspartate aminotransferase levels (P = 0.02) and decreased mean RBC (P < 0.001) and FFP usage (P = 0.009) compared to UW preservation solution use...
  15. ncbi request reprint Triple-phase computed tomography and intraoperative flow measurements improve the management of portosystemic shunts during liver transplantation
    Federico N Aucejo
    Departments of General Surgery and Radiology, Cleveland Clinic, Cleveland, OH 44195, USA
    Liver Transpl 14:96-9. 2008
    ..In conclusion, sustained good graft function and inflow were achieved in all 16 patients...
  16. ncbi request reprint Future prospects in immunosuppression for liver transplantation
    John J Fung
    Digestive Disease Institute, Cleveland Clinic, Cleveland, OH 44195, USA
    Liver Transpl 17:S54-9. 2011
    ....
  17. ncbi request reprint First U.S. near-total human face transplantation: a paradigm shift for massive complex injuries
    Maria Z Siemionow
    Department of Plastic and Reconstructive Surgery, Cleveland Clinic, Cleveland, Ohio 44195, USA
    Plast Reconstr Surg 125:111-22. 2010
    ..The authors describe establishment of the Cleveland Clinic face transplantation program that led them to perform the first U.S. near-total face transplantation...
  18. doi request reprint Role of vasodilation during normothermic machine perfusion of DCD porcine livers
    Ahmed Nassar
    Transplantation Center, Department of General Surgery, Cleveland Clinic, OH USA
    Int J Artif Organs 37:165-72. 2014
    ..We present our data on the impact of different vasodilators on DCD porcine livers preserved with NMP...
  19. pmc Post-liver transplantation sarcopenia in cirrhosis: a prospective evaluation
    Cynthia Tsien
    Department of Gastroenterology and Hepatology, Cleveland Clinic, Cleveland, Ohio, USA
    J Gastroenterol Hepatol 29:1250-7. 2014
    ..Pre-transplant sarcopenia (reduced skeletal muscle mass) predicts poor outcome in cirrhosis. In contrast, whether muscle mass increases post-orthotopic liver transplantation (OLT) is not known and was studied prospectively...
  20. pmc Hyperammonemia in cirrhosis induces transcriptional regulation of myostatin by an NF-κB-mediated mechanism
    Jia Qiu
    Departments of Pathobiology and Molecular Cardiology, Lerner Research Institute, Department of Gastroenterology, Digestive Disease Institute, and Departments of Hepatobiliary and Transplant Surgery and Molecular Genetics, Cleveland Clinic, Cleveland, OH 44195
    Proc Natl Acad Sci U S A 110:18162-7. 2013
    ..Our work provides unique insights into hyperammonemia-induced myostatin expression and suggests a mechanism by which sarcopenia develops in cirrhotic patients. ..
  21. doi request reprint Vascular endothelial growth factor receptor 2 expression in non-tumorous cirrhotic liver is higher when hepatoma is beyond Milan criteria
    Federico Aucejo
    Liver Transplantation, Cleveland Clinic, Cleveland, OH 44195, USA
    Liver Transpl 15:169-76. 2009
    ..Further investigation is needed to assess the value of angiogenesis modulation in preventing tumor formation and/or progression in cirrhotic patients...
  22. doi request reprint Cumulative risk of cardiovascular events after orthotopic liver transplantation
    Mazen Albeldawi
    Department of Gastroenterology and Hepatology, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA
    Liver Transpl 18:370-5. 2012
    ..Patients with posttransplant hypertension and diabetes, which are modifiable risk factors, are approximately twice as likely to experience a CV event...
  23. ncbi request reprint Lack of killer immunoglobulin-like receptor 2DS2 (KIR2DS2) and KIR2DL2 is associated with poor responses to therapy of recurrent hepatitis C virus in liver transplant recipients
    Medhat Askar
    Allogen Laboratories, Cleveland Clinic, Cleveland, OH, USA
    Liver Transpl 15:1557-63. 2009
    ..These findings support the role of natural killer and natural killer T cells in HCV clearance after LT and might be generalizable to treatment of HCV infection outside the setting of LT...
  24. doi request reprint Combined liver-kidney transplants: allosensitization and recipient outcomes
    Medhat Askar
    Transplant Center, Cleveland Clinic, Cleveland, OH, USA
    Transplantation 91:1286-92. 2011
    ..However, antibody-mediated rejection of the kidney in CLK has been reported recently. This prompted our study to investigate the impact of presensitization on CLK recipient outcomes...
  25. ncbi request reprint Impact of pretransplant rifaximin therapy on early post-liver transplant infections
    Jamak Modaresi Esfeh
    Departments of Gastroenterology and Hepatology, Digestive Disease Institute, Cleveland Clinic, Cleveland, OH
    Liver Transpl 20:544-51. 2014
    ..36). In conclusion, the use of rifaximin in the pre-LT period was not associated with an increased risk of bacterial or fungal infections in the early post-LT period...
  26. ncbi request reprint Pulmonary hypertension after liver transplantation in patients with antecedent hepatopulmonary syndrome: a report of 2 cases and review of the literature
    Federico Aucejo
    Departments of General Surgery, Cleveland Clinic Lerner College of Medicine, Cleveland Clinic, Cleveland, OH, USA
    Liver Transpl 12:1278-82. 2006
    ..This experience calls for better understanding of the pathogenesis of HPS and PPHTN and ways to better predict their occurrence...
  27. ncbi request reprint Role of tissue expanders in patients with loss of abdominal domain awaiting intestinal transplantation
    Melissa J Watson
    Department of General Surgery, Transplantation Center, Cleveland Clinic, Cleveland, OH, USA
    Transpl Int 26:1184-90. 2013
    ..In our preliminary experience, abdominal tissue expander placement is a safe, feasible, and well-tolerated method to increase subcutaneous domain and facilitate graft coverage in patients undergoing intestinal transplantation...
  28. doi request reprint Predicting the discharge status after liver transplantation at a single center: a new approach for a new era
    Dympna M Kelly
    Department of General Surgery, Cleveland Clinic Foundation, Cleveland, OH, USA
    Liver Transpl 18:796-802. 2012
    ..In conclusion, a new approach to improving the efficiency of hospital care is essential. We believe that this tool will aid in reducing lengths of stay and improving the experience of patients by facilitating early discharge planning...
  29. pmc Re-examination of sinusoidal deposition of complement 4d in liver allografts: experience from a single institution
    Mohannad Dugum
    Department of Internal Medicine, Medicine Institute, Cleveland Clinic Cleveland, OH, USA
    Int J Clin Exp Pathol 7:784-91. 2014
    ..This suggests that mechanisms other than allo-immunity activate complement. The mechanisms and clinical significance of C4d deposition in liver allografts in patients with PSC remain to be determined. ..
  30. ncbi request reprint Isolated right hepatic vein obstruction after piggyback liver transplantation
    Federico Aucejo
    Department of General Surgery, Cleveland Clinic Foundation, Cleveland, OH 44195, USA
    Liver Transpl 12:808-12. 2006
    ..In conclusion, all 3 patients developed recurrent ascites requiring angioplasty and/or stent placement across the right hepatic vein to alleviate the symptoms...
  31. pmc Hyperammonemia-mediated autophagy in skeletal muscle contributes to sarcopenia of cirrhosis
    Jia Qiu
    Departments of Pathobiology, Cleveland Clinic, Cleveland, Ohio 44195, USA
    Am J Physiol Endocrinol Metab 303:E983-93. 2012
    ..These observations show that increased skeletal muscle autophagy in cirrhosis is mediated by hyperammonemia and may contribute to sarcopenia of cirrhosis...
  32. ncbi request reprint The Cleveland Clinic FACES Score: a preliminary assessment tool for identifying the optimal face transplant candidate
    Chad R Gordon
    Department of Plastic Surgery, The Cleveland Clinic, 9500 Euclid Ave, Desk A 60, Cleveland, OH 44195, USA
    J Craniofac Surg 20:1969-74. 2009
    ..If substantiated, this supplemental score may ultimately predict successful outcomes, determine optimal utility, and provide insight toward prognosis with respect to facial composite tissue allotransplantation...
  33. ncbi request reprint Posttransplant metabolic syndrome: an epidemic waiting to happen
    Mangesh Pagadala
    Department of Gastroenterology and Hepatology, Digestive Disease Institute, Cleveland Clinic Foundation, Cleveland, OH 44195, USA
    Liver Transpl 15:1662-70. 2009
    ..Additional measures that may be potentially beneficial include the use of lipid-lowering agents, the optimal control of blood glucose, and the use of tacrolimus instead of cyclosporine...
  34. pmc Pregnancy after liver transplantation with tacrolimus immunosuppression: a single center's experience update at 13 years
    Ashokkumar B Jain
    Thomas E Starzl Transplantation Institute, Division of Transplantation, Department of Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania, USA
    Transplantation 76:827-32. 2003
    ..Tacrolimus has been increasingly used in solid-organ transplantation, and the effect of the drug on pregnancy is still of interest to clinicians. This study updates our single-center experience...
  35. ncbi request reprint Liver transplantation in patients with HIV infection
    John Fung
    Department of Surgery, Thomas E Starzl Transplantation Institute, University of Pittsburgh, Pittsburgh, PA, USA
    Liver Transpl 10:S39-53. 2004
    ..5. The degree of immunosuppression from iatrogenic drug therapy and HIV does not lead to increased risk of infectious complications...
  36. ncbi request reprint Effect of coadministered lopinavir and ritonavir (Kaletra) on tacrolimus blood concentration in liver transplantation patients
    Ashokkumar B Jain
    Department of Surgery, Division of Transplantation, Thomas E Starzl Transplantation Institute, University of Pittsburgh, Pittsburgh, PA, USA
    Liver Transpl 9:954-60. 2003
    ..Great caution is required in the management of tacrolimus dosage when Kaletra is introduced or withdrawn in HIV-positive patients after liver transplantation, particularly in the presence of hepatic dysfunction...
  37. ncbi request reprint Severe hemolysis resulting from D incompatibility in a case of ABO-identical liver transplant
    Mark K Fung
    Department of Pathology, University of Pittsburgh School of Medicine, Pennsylvania, USA
    Transfusion 44:1635-9. 2004
    ..Approximately 10 percent of ABO-compatible liver transplants involve a D- donor and a D+ recipient...
  38. ncbi request reprint Immunosuppression in liver transplantation: beyond calcineurin inhibitors
    John Fung
    Thomas E Starzl Transplantation Institute, Department of Surgery, University of Pittsburgh, 3459 Fifth Avenue, N755 MUH, Pittsburgh, PA 15213, USA
    Liver Transpl 11:267-80. 2005
    ..CNI-sparing protocols appear to be much more promising in balancing the early need for minimizing rejection while tapering doses and minimizing long-term toxicity...
  39. pmc Tolerogenic immunosuppression for organ transplantation
    Thomas E Starzl
    Thomas E Starzl Transplantation Institute, University of Pittsburgh Medical Center, Pittsburgh, PA 15213, USA
    Lancet 361:1502-10. 2003
    ..We aimed to apply these principles in recipients of renal and extrarenal organ transplants...
  40. pmc Use of alemtuzumab and tacrolimus monotherapy for cadaveric liver transplantation: with particular reference to hepatitis C virus
    Amadeo Marcos
    Thomas E Starzl Transplantation Institute, Pittsburgh, Pennsylvania, USA
    Transplantation 78:966-71. 2004
    ..Lymphoid depletion with alemtuzumab and minimalistic maintenance immunosuppression is a practical strategy of liver transplantation in HCV recipients but not HCV recipients...
  41. pmc Posttransplant lymphoproliferative disorders in liver transplantation: a 20-year experience
    Ashok Jain
    Thomas E Starzl Transplantation Institute, the Divisions of Transplantation Surgery and Transplantation Pathology, and the Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15213, USA
    Ann Surg 236:429-36; discussion 436-7. 2002
    ..To evaluate the incidence of posttransplant lymphoproliferative disease (PTLD) and the risk factors and the impact of this complication on survival outcomes in a large cohort of liver transplant recipients at a single institution...
  42. ncbi request reprint Using livers from donation after cardiac death donors--a proposal to protect the true Achilles heel
    John J Fung
    Liver Transpl 13:1633-6. 2007
  43. ncbi request reprint MELD and prediction of post-liver transplantation survival
    Shahid Habib
    Division of Gastroenterology, Hepatology and Nutrition, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA
    Liver Transpl 12:440-7. 2006
    ..Pretransplant MELD scores correlate inversely with posttransplant survival. However, better prognostic models are needed that would provide an overall assessment of transplant benefit relative to the severity of hepatic dysfunction...
  44. ncbi request reprint Preservation solutions in liver transplantation: what are the options?
    Bijan Eghtesad
    Liver Transpl 12:196-8. 2006
  45. pmc Immunosuppression for liver transplantation in HCV-infected patients: mechanism-based principles
    Bijan Eghtesad
    Thomas E Starzl Transplantation Institute, University of Pittsburgh Medical Center, Pittsburgh, PA, USA
    Liver Transpl 11:1343-52. 2005
    ....
  46. ncbi request reprint Liver transplantation for severe intrahepatic noncirrhotic portal hypertension
    Alyssa M Krasinskas
    Departments of Pathology, University of Pittsburgh, PA, USA
    Liver Transpl 11:627-34; discussion 610-1. 2005
    ..Importantly, however, a diagnosis of cirrhosis is not required in this group of patients to qualify them for OLT, and these patients have good long-term graft function after OLT...
  47. ncbi request reprint Pretransplant survival is shorter in HIV-positive than HIV-negative subjects with end-stage liver disease
    Margaret V Ragni
    Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213 4306, USA
    Liver Transpl 11:1425-30. 2005
    ..05. In conclusion, pretransplant survival appears shorter in HIV-positive OLTX candidates and is unrelated to severity of liver or HIV disease. Further study is warranted to determine risk factors for poorer pretransplant outcomes...
  48. ncbi request reprint Long-term outcome of adding mycophenolate mofetil to tacrolimus for nephrotoxicity following liver transplantation
    Ashokkumar Jain
    Department of Surgery, Transplant Division, Strong Memorial Hospital, University of Rochester, Rochester, NY 14642, USA
    Transplantation 80:859-64. 2005
    ..5% improvement at 1 year. Three patients developed renal failure. Six patients died in the follow-up period. Addition of MMF with reduced tacrolimus dose resulted in sustained improvement in renal function in 58% of patients...
  49. ncbi request reprint Intrahepatic biliary anatomy of living adult liver donors: correlation of mangafodipir trisodium-enhanced MR cholangiography and intraoperative cholangiography
    Vibhu Kapoor
    Department of Radiology, Division of Abdominal Imaging, University of Pittsburgh Medical Center, 200 Lothrop St, Pittsburgh, PA 15213, USA
    AJR Am J Roentgenol 179:1281-6. 2002
    ....
  50. ncbi request reprint Pathophysiologic observations and histopathologic recognition of the portal hyperperfusion or small-for-size syndrome
    Anthony J Demetris
    Department of Pathology, Thomas E Starzl Transplant Institute, University of Pittsburgh Medical Center, University of Pittsburgh, Pittsburgh, PA 15213, USA
    Am J Surg Pathol 30:986-93. 2006
    ..These findings suggest that portal hyperperfusion, venous pathology, and the arterial buffer response importantly contribute to early and late clinical and histopathologic manifestations of the small-for-size syndrome...
  51. ncbi request reprint Liver transplantation in precirrhotic biliary tract disease: Portal hypertension is frequently associated with nodular regenerative hyperplasia and obliterative portal venopathy
    Susan C Abraham
    Department of Pathology and Gastroenterology, Mayo Clinic, Rochester, MN 55905, USA
    Am J Surg Pathol 30:1454-61. 2006
    ..The occurrence of NRH in some patients transplanted for other indications suggests it is a histologic pattern that can precede the development of clinically significant portal hypertension...
  52. ncbi request reprint Ribavirin dose modification based on renal function is necessary to reduce hemolysis in liver transplant patients with hepatitis C virus infection
    Ashok B Jain
    Transplantation Institute, The Department of Surgery, University of Pittsburgh, Pittsburgh, PA 15213, USA
    Liver Transpl 8:1007-13. 2002
    ..Further pharmacokinetic studies of ribavirin in LTx patients with varying degrees of renal function may allow the development of an algorithm for the safer use of ribavirin in HCV-positive LTx patients...
  53. ncbi request reprint Pancreatitis after liver transplantation in children: a single-center experience
    Bijan Eghtesad
    The Thomas E Starzl Transplantation Institute and Children s Hospital of Pittsburgh, Pittsburgh, PA 15213, USA
    Transplantation 75:190-3. 2003
    ..We performed a retrospective review in a large cohort of pediatric liver transplant recipients at a single institution to define the impact of this problem in children...
  54. ncbi request reprint Dental health status of liver transplant candidates
    James Guggenheimer
    Department of Diagnostic Sciences, University of Pittsburgh School of Dental Medicine, Pittsburgh, PA 15261, USA
    Liver Transpl 13:280-6. 2007
    ..Edentulous patients should have periodic examinations for oral cancer...
  55. ncbi request reprint Liver transplantation for growing teratoma syndrome: report of a case
    Bijan Eghtesad
    Division of Transplantation Surgery, University of Pittsburgh, and the Thomas E Starzl Transplantation Institute, Pittsburgh, PA 15213, USA
    Liver Transpl 9:1222-4. 2003
    ..We discuss his postoperative management, follow-up, and briefly review literature on the subject...
  56. ncbi request reprint Dental management of the (solid) organ transplant patient
    James Guggenheimer
    University of Pittsburgh School of Dental Medicine, 3501 Terrace St, Pittsburgh, PA 15261, USA
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod 95:383-9. 2003
    ..This article reviews the current status of dental care practices that have been recommended and presents a rationale that can be applied as the basis for guidelines and recommendations for the treatment of the organ transplant patient...
  57. ncbi request reprint Extended follow-up of extended right lobe living donors: when is enough enough?
    Bijan Eghtesad
    Liver Transpl 12:199-200. 2006
  58. pmc Four-color flow cytometric analysis of peripheral blood donor cell chimerism
    Diana Metes
    Department of Surgery, Thomas E Starzl Tranplantation Institute, University of Pittsburgh Medical Center, Pittsburgh, PA 15261, USA
    Hum Immunol 64:787-95. 2003
    ..However, the detection of MHC-mismatched leukocytes of all lineages was much lower when frozen peripheral blood mononuclear cells were used...
  59. ncbi request reprint Diagnosis and treatment of intracardiac thrombosis during orthotopic liver transplantation
    Raymond M Planinsic
    Director of Hepatic Transplantation Anesthesiology, University of Pittsburgh Medical Center, 200 Lothrop Street, Room C 207, Pittsburgh, PA 15213, USA
    Anesth Analg 99:353-6, table of contents. 2004
    ..Transesophageal echocardiography was used to quickly diagnose the thrombus, allowing rapid pharmacological intervention and later guide surgical evacuation of the intracardiac thrombus via the inferior vena cava...
  60. ncbi request reprint Expanding the donor pool: safe transplantation of a cadaveric liver allograft with a 10 cm cavernous hemangioma--a case report
    Federico N Aucejo
    Department of General Surgery, Cleveland Clinic Foundation, Cleveland, OH 44195, USA
    Liver Transpl 12:687-9. 2006